当前位置:首页 - 行情中心 - 佰仁医疗(688198) - 财务分析 - 现金流量表

佰仁医疗

(688198)

  

流通市值:147.40亿  总市值:147.40亿
流通股本:1.38亿   总股本:1.38亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金428,045,257.95307,477,775.9120,772,963.64488,325,313.16
  收到其他与经营活动有关的现金25,066,359.9323,469,946.8717,298,209.3412,321,288.27
  经营活动现金流入小计453,111,617.88330,947,722.77138,071,172.98500,646,601.43
  购买商品、接受劳务支付的现金31,046,209.5124,930,139.0710,486,428.2859,157,812.38
  支付给职工以及为职工支付的现金122,207,975.9985,382,662.446,206,910.8131,624,469.35
  支付的各项税费57,253,128.3453,694,159.329,808,690.2823,061,387.05
  支付其他与经营活动有关的现金142,717,360.3791,657,417.5742,191,600.03150,571,659.24
  经营活动现金流出小计353,224,674.21255,664,378.34128,693,629.39364,415,328.02
  经营活动产生的现金流量净额99,886,943.6775,283,344.439,377,543.59136,231,273.41
二、投资活动产生的现金流量:
  收回投资收到的现金---6,000,000
  取得投资收益收到的现金10,921,895.262,044,049.05328,995.7713,244,633.93
  处置固定资产、无形资产和其他长期资产收回的现金净额1,026.291,028.03-15,375.71
  收到的其他与投资活动有关的现金821,200,000536,400,000209,500,0001,010,800,000
  投资活动现金流入小计832,122,921.55538,445,077.08209,828,995.771,030,060,009.64
  购建固定资产、无形资产和其他长期资产支付的现金103,960,911.488,933,082.3429,800,617.84163,255,476.67
  取得子公司及其他营业单位支付的现金---10,835,686.1
  支付其他与投资活动有关的现金831,800,000429,300,000169,000,0001,132,200,000
  投资活动现金流出小计935,760,911.4518,233,082.34198,800,617.841,306,291,162.77
  投资活动产生的现金流量净额-103,637,989.8520,211,994.7411,028,377.93-276,231,153.13
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,333,603.35--14,482,969.65
  取得借款收到的现金75,000,00065,000,00025,000,000-
  筹资活动现金流入小计80,333,603.3565,000,00025,000,00014,482,969.65
  分配股利、利润或偿付利息支付的现金110,433,947.55110,075,497.56-109,263,392
  支付其他与筹资活动有关的现金2,958,979.572,308,344.091,149,906.264,254,053.67
  筹资活动现金流出小计113,392,927.12112,383,841.651,149,906.26113,517,445.67
  筹资活动产生的现金流量净额-33,059,323.77-47,383,841.6523,850,093.74-99,034,476.02
四、汇率变动对现金及现金等价物的影响-114,344.48-4,963.34-56,037.528,032.5
五、现金及现金等价物净增加额-36,924,714.4348,106,534.1844,199,977.74-239,026,323.24
  加:期初现金及现金等价物余额55,549,807.2555,549,807.2555,549,807.25294,576,130.49
  期末现金及现金等价物余额18,625,092.82103,656,341.4399,749,784.9955,549,807.25
补充资料:
  净利润-65,459,399.49-132,143,495.69
  固定资产和投资性房地产折旧-12,984,603.12-12,593,894.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,984,603.12-12,593,894.54
  无形资产摊销-3,813,606.53-7,152,489.01
  长期待摊费用摊销-2,132,987.28-2,229,186.62
  处置固定资产、无形资产和其他长期资产的损失--1,753.37--1,095.74
  固定资产报废损失---50,047.86
  公允价值变动损失--8,921.33--742,302.66
  财务费用-643,274.2-409,068.52
  投资损失--4,838,321.34--10,011,207.19
  递延所得税--2,712,112.86-9,968,559.15
  其中:递延所得税资产减少--2,263,126.91-9,349,941.99
    递延所得税负债增加--448,985.95-618,617.16
  存货的减少--16,468,643.8--17,840,803.93
  经营性应收项目的减少-3,546,911.69--63,035,429.77
  经营性应付项目的增加-9,525,920.39-39,292,236.53
  其他---18,123,913.04
  不涉及现金收支的投资和筹资活动金额其他项目---1,285,986.79
  现金的期末余额-103,656,341.43-55,549,807.25
  减:现金的期初余额-55,549,807.25-294,576,130.49
  现金及现金等价物的净增加额-48,106,534.18--239,026,323.24
公告日期2025-10-312025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑